Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial

The recent Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) trial reported a reduction in child mortality following biannual azithromycin mass drug administration (MDA). Here, we investigate the financial costs and cost-effectiveness from the health provider perspectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, John D., Kalua, Khumbo, Keenan, Jeremy D., Lietman, Thomas M., Bailey, Robin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470598/
https://www.ncbi.nlm.nih.gov/pubmed/32342840
http://dx.doi.org/10.4269/ajtmh.19-0622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470598/
https://www.ncbi.nlm.nih.gov/pubmed/32342840
http://dx.doi.org/10.4269/ajtmh.19-0622

Ejemplares similares